199 related articles for article (PubMed ID: 17674311)
41. Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.
Revello MG; Lilleri D; Zavattoni M; Furione M; Genini E; Comolli G; Gerna G
J Infect Dis; 2006 Jan; 193(2):269-76. PubMed ID: 16362891
[TBL] [Abstract][Full Text] [Related]
42. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.
Lacey SF; La Rosa C; Zhou W; Sharma MC; Martinez J; Krishnan A; Gallez-Hawkins G; Thao L; Longmate J; Spielberger R; Forman SJ; Limaye A; Zaia JA; Diamond DJ
J Infect Dis; 2006 Nov; 194(10):1410-21. PubMed ID: 17054071
[TBL] [Abstract][Full Text] [Related]
43. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
[TBL] [Abstract][Full Text] [Related]
44. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
[No Abstract] [Full Text] [Related]
45. Induction of recipient cell-specific donor T-cell anergy by UV-C-irradiated recipient immature monocyte-derived dendritic cells.
Tochiki N; Narita M; Zheng Z; Lu C; Saitoh A; Watanabe N; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Bone Marrow Transplant; 2008 Jun; 41(12):1037-45. PubMed ID: 18332913
[TBL] [Abstract][Full Text] [Related]
46. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide.
Qin H; Vlad G; Cortesini R; Suciu-Foca N; Manavalan JS
Hum Immunol; 2008 Nov; 69(11):776-80. PubMed ID: 18848854
[TBL] [Abstract][Full Text] [Related]
47. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.
Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N
J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273
[TBL] [Abstract][Full Text] [Related]
48. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
[TBL] [Abstract][Full Text] [Related]
49. Human cytomegalovirus vaccine: time to look for alternative options.
Khanna R; Diamond DJ
Trends Mol Med; 2006 Jan; 12(1):26-33. PubMed ID: 16337831
[TBL] [Abstract][Full Text] [Related]
50. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
[TBL] [Abstract][Full Text] [Related]
51. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
Forsberg O; Carlsson B; Tötterman TH; Essand M
Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
[TBL] [Abstract][Full Text] [Related]
52. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
53. Recent developments in human cytomegalovirus diagnosis.
Halwachs-Baumann G
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):427-39. PubMed ID: 17547507
[TBL] [Abstract][Full Text] [Related]
54. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
[TBL] [Abstract][Full Text] [Related]
55. Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
Hall S; Danby R; Osman H; Peniket A; Rocha V; Craddock C; Murphy M; Chaganti S
Transfus Med; 2015 Dec; 25(6):418-23. PubMed ID: 26114211
[TBL] [Abstract][Full Text] [Related]
56. UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.
Garrigue I; Faure-Della Corte M; Magnin N; Recordon-Pinson P; Couzi L; Lebrette ME; Schrive MH; Roncin L; Taupin JL; Déchanet-Merville J; Fleury H; Lafon ME
Transplantation; 2008 Sep; 86(6):826-35. PubMed ID: 18813108
[TBL] [Abstract][Full Text] [Related]
57. Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.
Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; Hernández-Boluda JC; Remigia MJ; Jarque I; Calabuig ML; Garcia-Noblejas A; Alberola J; Tamarit A; Gimeno C; Navarro D
Haematologica; 2008 Sep; 93(9):1434-6. PubMed ID: 18603553
[No Abstract] [Full Text] [Related]
58. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
59. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.
Morita-Hoshi Y; Heike Y; Kawakami M; Sugita T; Miura O; Kim SW; Mori SI; Fukuda T; Tanosaki R; Tobinai K; Takaue Y
Bone Marrow Transplant; 2008 Mar; 41(6):515-21. PubMed ID: 18026143
[TBL] [Abstract][Full Text] [Related]
60. Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
Gervais A; Eymard JC; Toulmonde E; Bernard J
Cancer Immunol Immunother; 2009 Nov; 58(11):1831-41. PubMed ID: 19330330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
